Sanofi India Ltd - 500674 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Annual Report for the Financial Year ended 31st December 2023 along with the Notice of the 68th Annual General Meeting (AGM) which is scheduled to be held on 14th May 2024 through Video Conferencing facility / Other Audio-Visual Means, for your information and records. Sanofi India Ltd - 500674 - Notice Of Sixty Eighth Annual General Meeting Of Sanofi India Limited
Notice of the Sixty Eighth Annual General Meeting of Sanofi India Limited to be held on May 14, 2024 at 3:30 p.m. (IST) through Video Conferencing/ Other Audio-Visual Means. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced,. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosures Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s). Sanofi eyes for accelerated growth in India; plans fast-tracking of product pipeline
Sanofi has a pipeline of 12 different products lined up for launch in the country. Sanofi gets nod for new polio vaccine in India
The vaccine has the same composition/formulation as ShanIPV, the spokesperson added
Sanofi Gets Nod For New Polio Vaccine In India
Sanofi has received approval for IMOVAX-Polio, an alternative injectable vaccine, to replace ShanIP, the inactivated polio vaccine, in India. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the newspaper publication related to notice of the Annual General Meeting, which will be held through video conferencing facility on 14th May 2024. Sanofi India Ltd - 500674 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 31st March 2024 under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Request you to take the above certificate on record.
Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
Sanofi did not disclose the financial terms of the deal. The agreement, which still needs to be finalized, will resolve most of the lawsuits against the French pharmaceutical company in U.S. state courts, with the exception of Delaware where the majority of the cases are pending.